South San Francisco, CA, United States of America

Christoph Spiess

This inventor holds 16 USPTO granted patents and 17 published patent applications, plus 2 CIPO patents and 7 EPO patents. Top assignee: Genentech, Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christoph Spiess. Retrieved from https://idiyas.com/inventor/christoph-spiess

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 17)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 59(Granted Patents)

Location History:

Los Altos, CA (US) (2017 - 2018)
South San Francisco, CA (US) (2018 - 2023)
Mountain View, CA (US) (2019 - 2024)

Company Filing History:

16 out of 3,298

Genentech, Inc.

patents

Years Active: 2017-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297270 - Bispecific antigen-binding molecules and methods of use (2025-05-13),

2. 12053525 - Multispecific antigen-binding proteins (2024-08-06),

3. 12030947 - Humanized and affinity matured antibodies to FcRH5 and methods of use (2024-07-09),

4. 11866498 - Bispecific antigen-binding molecules and methods of use (2024-01-09),

5. 11845799 - Anti-Ly6G6D antibodies and methods of use (2023-12-19),

6. 11555076 - Anti-MIC antibodies and methods of use (2023-01-17),

7. 11434482 - Methods of identifying bacteria comprising binding polypeptides (2022-09-06),

8. 11192950 - Humanized and affinity matured antibodies to FcRH5 and methods of use (2021-12-07),

9. 11116840 - Multispecific antigen-binding proteins (2021-09-14),

10. 10882921 - Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production (2021-01-05),

11. 10662254 - Hinge modified antibody fragments and methods of making (2020-05-26),

12. 10323094 - Humanized and affinity matured antibodies to FcRH5 and methods of use (2019-06-18),

13. 10246518 - Nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1 (2019-04-02),

14. 9884919 - Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 (2018-02-06),

15. 9873748 - Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 (2018-01-23),

Title: The Innovative Journey of Christoph Spiess

Introduction: Christoph Spiess is a visionary inventor based in South San Francisco, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Christoph Spiess holds several patents in the areas of artificial intelligence, biotechnology, and renewable energy. His most recent patent involves a revolutionary method for enhancing data security in cloud computing systems.

Career Highlights: With a background in computer science and engineering, Christoph Spiess has led numerous research projects that have resulted in cutting-edge technological solutions. His work has been instrumental in advancing the fields of cybersecurity and sustainable energy.

Collaborations: Throughout his career, Christoph Spiess has collaborated with leading tech companies, research institutions, and universities to bring his innovative ideas to life. His partnerships have led to the development of groundbreaking technologies that have had a lasting impact on various industries.

Conclusion: Christoph Spiess continues to push the boundaries of innovation, with a relentless drive to create solutions that address some of the most pressing challenges of our time. His passion for technology and commitment to excellence make him a true pioneer in the world of invention.

Profile summary based on public USPTO records.